Shirley M. Clift

Nessuna posizione attualmente

Health Technology

Consumer Services

Precedenti posizioni note di Shirley M. Clift

Società	Posizione	Inizio	Fine
SANGAMO THERAPEUTICS, INC.	Consigliere Generale	01/01/2010	01/01/2019
Cell Genesys, Inc. Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer.	Consigliere Generale	01/01/2009	01/01/2009

University of California, Berkeley

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

General Counsel	2
Undergraduate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SANGAMO THERAPEUTICS, INC.	Health Technology

Aziende private	1
Cell Genesys, Inc. Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer.	Health Technology

Aziende private

Health Technology